19 May 2013
Keywords: novartis/genentech, deal, lucentis, novartis, genentech, signed, agreement
Article | 07 July 2003
Novartis and Genentech have signed an agreement under which the former has gained an exclusive license to develop and commercialize ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 July 2003
30 June 2003
17 May 2013
© 2013 thepharmaletter.com